Literature DB >> 20465394

Clinical, pathological and molecular determinants in squamous cell carcinoma of the oral cavity.

Jamil N Al-Swiahb1, Chang-Han Chen, Hui-Ching Chuang, Fu-Min Fang, Hsin-Ting Tasi, Chih-Yen Chien.   

Abstract

Squamous cell carcinoma of the oral cavity (OCSCC) is the most frequently observed form of head-and-neck cancer in Southeast Asia and is the sixth most common cancer worldwide. Most cases of this preventable disease are caused by alcohol consumption, smoking and betel nut chewing. The survival rates of patients with advanced OCSCC have not increased significantly in recent years. While treatments for OCSCC are similar worldwide, survival rates differ by geographical area. The various genetic profiles and individual genetic susceptibility for carcinogens may account for this discrepancy. In some respects, molecular alteration or accumulation affects tumor progression and the clinical outcomes among patients with OCSCC. Clarifying the tumor behavior of oral cancer, with regard to pathological features or molecular aspects, could help clinicians to judge, tailor and adopt more effective therapeutic strategies to treat oral cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20465394     DOI: 10.2217/fon.10.35

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  17 in total

1.  The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL.

Authors:  Francesco Carinci; Lorenzo Monasta; Corrado Rubini; Daniela Stramazzotti; Annalisa Palmieri; Elisabetta Melloni; Alex Knowles; Luca Ronfani; Giorgio Zauli; Paola Secchiero
Journal:  Invest New Drugs       Date:  2010-11-18       Impact factor: 3.850

2.  Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma.

Authors:  Liang Ding; Bing Li; Ying Zhao; Yi-Fu Fu; Er-Ling Hu; Qin-Gang Hu; Yan-Hong Ni; Ya-Yi Hou
Journal:  Tumour Biol       Date:  2014-07-25

3.  The role of CXCR2 chemokine receptors in the oral squamous cell carcinoma.

Authors:  Juliana Romanini; Tânia R Mielcke; Paulo C Leal; Cláudia P Figueiredo; João B Calixto; Fernanda B Morrone; Eraldo L Batista; Maria M Campos
Journal:  Invest New Drugs       Date:  2011-06-14       Impact factor: 3.850

4.  Pro-inflammatory genes as biomarkers and therapeutic targets in oral squamous cell carcinoma.

Authors:  Shailaja K Rao; Zoran Pavicevic; Ziyun Du; Jong-Gwan Kim; Meiyun Fan; Yan Jiao; Molly Rosebush; Sandeep Samant; Weikuan Gu; Lawrence M Pfeffer; Christopher A Nosrat
Journal:  J Biol Chem       Date:  2010-08-11       Impact factor: 5.157

5.  Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells.

Authors:  Sudha Krishnamurthy; Kristy A Warner; Zhihong Dong; Atsushi Imai; Carolina Nör; Brent B Ward; Joseph I Helman; Russell S Taichman; Emily L Bellile; Laurie K McCauley; Peter J Polverini; Mark E Prince; Max S Wicha; Jacques E Nör
Journal:  Stem Cells       Date:  2014-11       Impact factor: 6.277

6.  TRF2 Overexpression at the Surgical Resection Margin: A Potential Predictive Biomarker in Oral Squamous Cell Carcinoma for Recurrence.

Authors:  Madhabananda Kar; Mahesh Sultania; Souvick Roy; Swatishree Padhi; Birendranath Banerjee
Journal:  Indian J Surg Oncol       Date:  2020-02-19

7.  Promoter Hypermethylation of LATS1 Gene in Oral Squamous Cell Carcinoma (OSCC) among North Indian Population.

Authors:  Harsh Goel; Runjhun Mathur; Saima Syeda; Anju Shrivastava; Abhimanyu Kumar Jha
Journal:  Asian Pac J Cancer Prev       Date:  2021-03-01

8.  Nonadhesive culture system as a model of rapid sphere formation with cancer stem cell properties.

Authors:  Su-Feng Chen; Yun-Ching Chang; Shin Nieh; Chia-Lin Liu; Chin-Yuh Yang; Yaoh-Shiang Lin
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

9.  Human papillomavirus 16 (HPV16) enhances tumor growth and cancer stemness of HPV-negative oral/oropharyngeal squamous cell carcinoma cells via miR-181 regulation.

Authors:  Sung Hee Lee; Chang-Ryul Lee; Nicole Kristina Rigas; Reuben H Kim; Mo K Kang; No-Hee Park; Ki-Hyuk Shin
Journal:  Papillomavirus Res       Date:  2015-12-01

10.  Quercetin suppresses drug-resistant spheres via the p38 MAPK-Hsp27 apoptotic pathway in oral cancer cells.

Authors:  Su-Feng Chen; Shin Nieh; Shu-Wen Jao; Chia-Lin Liu; Chien-Hua Wu; Yun-Ching Chang; Chin-Yuh Yang; Yaoh-Shiang Lin
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.